Press Releases

Assay is now available in Mexico and countries that accept CE mark Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced the introduction of its next-generation Anti-T. cruzi assay, with CE Mark approval and approval for use in Mexico.
Sep 28, 2018
Jay Snyder, head of Business Fields – Clinical Lab Platforms, discusses with MD+DI Ortho's VITROS ®  XT 7600 and its impact on the clinical lab environment. Read the article.   Press contact: For media inquiries please contact Ortho Media Relations Ortho Clinical Diagnostics
Aug 27, 2018
Displaying 81 - 90 of 116